Skip to main content
Premium Trial:

Request an Annual Quote

Gene Logic Patents "Differential Display" Genomics Technology

Premium

GAITHERSBURG, Md.--Gene Logic here announced that it was issued a US patent for an enzyme-based genomics technology, "differential display," in which restriction enzymes reveal differences in gene expression among various tissue samples. Gene Logic said that methods based on the approach covered by the patent are more suitable for industrial-scale operations than a differential display method that doesn't require restriction enzymes.

Gene Logic holds an exclusive worldwide license on the patent from the New York Blood Center, whose broad patent covers a variety of methods that involve use of restriction enzymes to generate differential gene-expression patterns.

The new patent broadens protection for Gene Logic's Restriction Enzyme Analysis of Differentially Expressed Sequences display technology, the basis for the company's largest revenue-generating business.

Filed under

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.